Total consumer industry cross border M&A deals worth $193.53m were announced in Europe in March 2021, led by Siniora Food Industries’ $28.3m acquisition of Trakya ET, according to GlobalData’s deals database.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 62.9% over the previous month of $522.25m and a drop of 76.01% when compared with the last 12-month average of $806.55m.

Europe held a 22.13% share of the global consumer industry cross border M&A deal value that totalled $874.32m in March 2021. With a 14.86% share and deals worth $129.9m, the UK was the top country in Europe’s cross border M&A deal value across consumer industry.

In terms of cross border M&A deal activity, Europe recorded 34 deals during March 2021, marking an increase of 30.77% over the previous month and a rise of 54.55% over the 12-month average. The UK recorded 14 deals during the month.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Europe consumer industry cross border M&A deals in March 2021: Top deals

The top five consumer industry cross border M&A deals accounted for 37.6% of the overall value during March 2021.

The combined value of the top five consumer cross border deals stood at $72.68m, against the overall value of $193.53m recorded for the month.

The top five consumer industry cross border M&A deals of March 2021 tracked by GlobalData were:

1) Siniora Food Industries’ $28.3m acquisition of Trakya ET

2) The $13.94m acquisition of Marathon Foods by Laita PGC

3) KN holding’s $11.9m acquisition of TUI Russia & CIS

4) The $10.44m acquisition of Chrisal by HeiQ

5) Yooma’s acquisition of EMMAC Life Sciences for $8.1m.